Study concept and design: Schmidt, Davis, Solimano, Roberts.
Acquisition of data: All authors.
Analysis and interpretation of data: Schmidt, Roberts.
Drafting of the manuscript: Schmidt.
Critical revision of the manuscript for important intellectual content: Davis, Asztalos, Solimano, Roberts.
Statistical analysis: Roberts.
Obtained funding: Schmidt, Asztalos, Roberts.
Administrative, technical, or material support: Schmidt, Davis, Solimano.
Study supervision: Schmidt, Davis, Solimano.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
Funding/Support: The Caffeine for Apnea of Prematurity trial was supported by grant MCT 13288 from the Canadian Institutes of Health Research and by the National Health and Medical Research Council of Australia.
Role of the Sponsors: Canadian Institutes of Health Research and the National Health and Medical Research Council of Australia had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: In addition to the named authors, the following members of the Steering Committee for the 5-Year Follow-Up of the Caffeine for Apnea of Prematurity trial participants contributed to the manuscript: Lex W. Doyle, MD, MSc, Peter J. Anderson, PhD, Ruth E. Grunau, PhD, Arne Ohlsson, MD, MSc, Deborah Dewey, PhD, Diane Moddemann, MD, MEd, and Win Tin, MD. None of the additional contributors received any compensation for their contributions to this study.